Recombinant Anti-Trastuzumab Antibody Fab Fragment (CAT#: MOB-1002-F(E))

1. Q 1: What are the applications of the Anti-Trastuzumab antibody in research?

   A: The Anti-Trastuzumab antibody Fab fragment is utilized primarily in immunoprecipitation and radioimmunoassay. These applications support the detailed analysis and investigation of breast cancer, particularly involving trastuzumab, a therapeutic agent used for HER2-positive cancers. The Fab fragment's specificity and purity (>95% by SDS-PAGE) make it an excellent choice for precise studies where minimizing host cell protein contamination is crucial.

2. Q 2: How does HER2 contribute to breast cancer, and how does this antibody aid its study?

   A: HER2 is an oncoprotein whose overexpression is linked to aggressive breast cancer types. By targeting HER2, trastuzumab-mediated therapies inhibit cell proliferation. The Recombinant Anti-Trastuzumab recognizes the trastuzumab antigen, thereby facilitating investigations into HER2-pathology mechanisms, aiding in identifying effective therapeutic strategies by providing insights through detailed immunoassays.

3. Q 3: What are the unique storage and stability properties of this antibody?

   A: This Fab fragment maintains potency when stored at -20°C, with minimal freeze/thaw cycles. Its stability under these conditions makes it suitable for long-term research projects, ensuring that researchers have access to a consistent, reliable reagent over time.

View the frequently asked questions answered by Creative Biolabs Support.